
If your Botox treatment seems not to be working, it does not automatically mean that you are resistant to botulinum toxin. A reduced or absent effect can have several explanations, including when you assess the result, the treatment plan, the muscles treated, the dose and injection technique.
Some people notice no obvious change, while others see a partial effect or find that a treatment which previously worked appears less effective. These situations should be assessed separately rather than assuming that the solution is simply more Botox.
“Botox” is commonly used as a general term, but Botox is a specific brand of botulinum toxin type A. Different botulinum toxin products are available, and their doses cannot automatically be compared unit for unit.

“Botox not working” can describe several different treatment outcomes. Identifying which one applies is useful because they do not necessarily have the same explanation.
You may mean that:
you have noticed no meaningful reduction in the movement that was being treated;
there is an effect, but it is weaker than you expected;
one part of the treated area has responded differently from another;
the treatment initially worked but the effect seemed to fade sooner than expected; or
previous treatments worked reliably, but recent treatments appear progressively less effective.
A treatment that appears weak is therefore not automatically the same as genuine resistance to botulinum toxin.
If your main concern is that a normal-looking initial result disappeared sooner than expected, our guide to how long Botox lasts covers duration in more detail.
You cannot see a meaningful change in the movement or area that was intended to be treated.
Some movement has reduced, but the overall response is less than you expected or different between parts of the treated area.
You initially noticed a result, but it did not appear to persist as expected.
Previous treatments produced a clear response, but later treatments appear progressively weaker or ineffective.
There is no single explanation for an apparently unsuccessful botulinum toxin treatment. A treatment review should consider the circumstances of that specific session rather than assuming that your body has become “immune” to Botox.
Botulinum toxin does not create its full visible effect immediately after injection. The onset and assessment point can differ according to the product, treatment area and treatment plan.
If only a short time has passed, follow the review timing given by your treating clinic rather than judging the treatment immediately.
The amount used is one part of treatment planning. Too little toxin for the intended treatment may contribute to an inadequate response.
This does not mean that receiving more toxin is automatically the correct next step. The previous treatment and response should first be reviewed.
Botulinum toxin is targeted to specific muscles. If the selected muscles do not adequately correspond with the movement responsible for the treatment concern, the visible result may differ from what was intended.
Individual facial muscle activity also varies. The same treatment pattern does not necessarily produce the same response in every person.
Placement and injection technique are recognised considerations when investigating treatment failure.
This is one reason a review should look at the original treatment plan rather than evaluating the result only from the number of units used.
A reduced response and an unrealistic treatment expectation are not the same thing.
For example, reduced muscle movement does not necessarily mean that every visible line or feature will disappear. During a review, the practitioner can compare the intended treatment objective with what actually changed.
Not directly. The units used for one botulinum toxin preparation are not automatically interchangeable with the units of another product.
This means that comparing only the number written on two treatment records may be misleading if different products were used.
If you have changed clinic or product, bring the name of the previous product and treatment record to your review where possible.
Not necessarily. An uneven or incomplete response still provides useful information about which areas responded and which did not.
The treating clinic can assess movement and compare the result with the original treatment plan.
No. Dose requirements and treatment planning can vary between individuals and treatment areas.
Resistance should not be diagnosed simply because one treatment required adjustment or produced a weaker result.
Other people's results do not establish how your treatment should respond. Muscle activity, anatomy, treatment objective, product and treatment plan can differ.
Your own pretreatment appearance and movement are a more relevant comparison where photographs or clinical records are available.
Yes, reduced biological response to botulinum toxin can occur, including through the development of neutralising antibodies. However, one disappointing treatment does not prove that you have developed Botox resistance.
Neutralising antibodies can interfere with the biological activity of botulinum toxin and may reduce the effectiveness of later treatment. Genuine antibody-related non-response is therefore a recognised possibility, but it is only one potential explanation among several.
A pattern in which previously successful botulinum toxin treatments become progressively less effective may give a practitioner a reason to investigate secondary non-response. The treatment history, dose, product, injection plan and actual muscle response still need to be considered.
Do not assume that resistance can be confirmed from appearance alone.
A treatment that worked previously but appears weaker on a later occasion does not have one automatic explanation.
Useful details to compare include:
which botulinum toxin product was used;
which area or muscles were treated;
the dose used;
when the treatment was performed;
when you first noticed an effect;
whether there was a partial response;
how the current result differs from previous treatments; and
whether reduced response has occurred once or repeatedly.
This distinction matters. A single treatment that produced an unexpected result is different from a consistent pattern of diminishing response across repeated treatments.
If the result is accompanied by a possible adverse effect rather than simply a lack of effect, read the separate guide to Botox complications.
Start by checking how long it has been since treatment and what change was originally intended. If you are still within the period in which your clinic expects the effect to develop, follow the review plan you were given.
If the expected review point has passed and you see little or no effect, contact the clinic that performed the injections. Explain exactly what has changed and what has not.
Photographs taken before treatment can be useful because they allow your current movement and appearance to be compared with your own baseline rather than another person's result.
If possible, keep a record of the:
treatment date;
product used;
areas treated;
dose recorded by the clinic;
date you first noticed an effect; and
date you felt the effect had reduced.
Do not assume that an immediate additional injection is necessarily appropriate. The possible reason for the reduced response should first be considered.
If you still see little or no meaningful change two weeks after treatment, contact the treating clinic and ask whether the result should now be reviewed based on the product, area and treatment plan used.
Two weeks should not be presented as a universal scientific deadline for every botulinum toxin treatment. Different products and indications have their own clinical information, and the clinic should tell you when it expects to assess your individual treatment.
The important point is not to diagnose resistance yourself or arrange repeated injections simply because the result seems incomplete.
A treatment review is an opportunity to determine what actually responded before deciding what, if anything, should happen next.
The practitioner may assess:
movement in the treated area;
whether any part of the intended muscle activity has reduced;
baseline and current photographs where available;
the original treatment area;
the product used;
the recorded dose;
injection locations;
your previous response to botulinum toxin; and
whether reduced response has happened repeatedly.
If there has been no meaningful response, the possible explanations can then be considered more systematically.
For broader information about botulinum toxin treatment rather than treatment failure, see the main Botox guide.
Neutralising antibodies are antibodies capable of interfering with the biological activity of botulinum toxin. Their formation is one recognised reason why treatment can become less effective.
Their possible presence should not be assumed from one disappointing cosmetic result.
Secondary non-response describes a situation in which treatment previously produced a response but becomes less effective after subsequent treatments.
It describes the response pattern rather than proving its cause. A practitioner still needs to consider treatment-related explanations and the person's treatment history.
UK prescribing information for some botulinum toxin products warns that higher doses or more frequent treatment intervals may increase the likelihood of antibody formation.
This does not mean that an individual treatment schedule should be changed without clinical assessment.
Do not assume that changing products will automatically solve a reduced response. Different botulinum toxin preparations have their own formulation and dosing systems, and the cause of the apparent treatment failure should first be assessed.
For a broader explanation of product differences, see comparing botulinum toxin treatments.
Not automatically.
If the first treatment appears weaker than expected, the useful next question is why. Adding more toxin without considering the original dose, treated muscles, product, injection plan and response may fail to address the underlying reason.
The appropriate next step can differ depending on whether there has been no response, a partial response, an uneven response or a pattern of reduced response after previously successful treatments.
A practitioner can assess this during a treatment review and discuss whether any further treatment is appropriate in your individual circumstances.
If you are considering a consultation with another clinic, compare more than the advertised treatment price.
Useful information to discuss includes who will assess you, which botulinum toxin product is being considered, how the treatment plan is documented and how follow-up is handled when the effect differs from what was expected.
Bring details of previous botulinum toxin treatments where possible. A history of which products, areas and doses you received can give the practitioner more useful context than simply saying that “Botox stopped working”.
Compare on experience & price Make an appointment immediately
There can be several reasons. The result may have been assessed too early, or factors such as the treatment plan, dose, muscles treated or injection technique may affect the response. Neutralising antibodies are another possible explanation, but one weak treatment does not prove resistance.
If there is still little or no meaningful change after two weeks, contact the clinic that treated you and ask whether it is time for a review. Do not automatically assume that you are resistant or arrange additional injections without first reviewing the original treatment.
Yes, reduced response associated with neutralising antibodies can occur. However, genuine resistance is only one possible explanation for treatment failure and cannot be established simply because one treatment was disappointing.
People often use “immune” to describe Botox resistance. More precisely, neutralising antibodies can sometimes interfere with the biological effect of botulinum toxin. A weak treatment result alone does not confirm that this has happened.
The product, dose, muscles treated, injection locations, treatment timing and your actual response should all be compared. One different result is not enough to identify the cause.
No. Treatment plans and doses can vary. Resistance should not be assumed because a practitioner considers adjusting a treatment plan or because one treatment produced a weaker effect.
No. Units from different botulinum toxin preparations are not automatically interchangeable. Comparing treatments only by their unit number can therefore be misleading when different products were used.
Do not assume that more toxin is automatically the solution. The original treatment and response should first be reviewed so that possible reasons for the reduced effect can be considered.
Search, compare and book a injectable or filler treatment
Injectablesbooking.co.uk part of Halftien BV
info@injectablesbooking.co.uk
KVK: 81484879
BTW: NL862111808B01